Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

47.66USD
26 May 2015
Change (% chg)

$0.03 (+0.06%)
Prev Close
$47.63
Open
$47.52
Day's High
$47.81
Day's Low
$47.51
Volume
102,178
Avg. Vol
779,106
52-wk High
$47.99
52-wk Low
$30.43

ZTS.N

Chart for ZTS.N

About

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company markets products across four regions: the United States, Europe/Africa/Middle East, Canada/Latin America and Asia/Pacific; eight... (more)

Overall

Beta: --
Market Cap(Mil.): $23,813.30
Shares Outstanding(Mil.): 499.96
Dividend: 0.08
Yield (%): 0.70

Financials

  ZTS.N Industry Sector
P/E (TTM): 40.37 37.10 39.11
EPS (TTM): 1.18 -- --
ROI: 11.61 16.22 15.56
ROE: 50.36 16.99 16.57
Search Stocks

Deals of the day- Mergers and acquisitions

May 5 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

06 May 2015

UPDATE 2-Zoetis to cut up to 2,500 jobs, shut storage units

* Shares up 0.6 pct in afternoon trading (Adds CEO comments, analyst comments, details; updates shares)

05 May 2015

CORRECTED-Zoetis to reduce operations in Venezuela, considers selling plants

May 5 - Animal health products maker Zoetis Inc said it would reduce operations in Venezuela and consider selling or exiting 10 manufacturing sites over the long term.

05 May 2015

Zoetis adds 2nd director to board under deal with Pershing Square

April 13 - Animal health products company Zoetis Inc appointed a second director to its board under its agreement with Bill Ackman's hedge fund Pershing Square Capital Management.

13 Apr 2015

UPDATE 1-U.S. developing bird flu vaccine, no distribution plans yet

CHICAGO, March 23 - The U.S. government is developing a vaccine to protect poultry from new strains of avian flu that have recently killed birds from Arkansas to Washington state.

24 Mar 2015

Hedge fund Pershing Square wins board seat at Zoetis

BOSTON - Hedge fund Pershing Square Capital Management won one seat on the board of directors of animal health company Zoetis Inc and agreed with management to select a second "mutually agreeable" director, Zoetis said on Wednesday.

05 Feb 2015

Hedge fund Pershing Square wins board seat at Zoetis

BOSTON, Feb 4 - Hedge fund Pershing Square Capital Management won one seat on the board of directors of animal health company Zoetis Inc and agreed with management to select a second "mutually agreeable" director, Zoetis said on Wednesday.

04 Feb 2015

Deals of the day- Mergers and acquisitions

Jan 29 - The following bids, mergers, acquisitions and disposals were reported by 1115 GMT on Thursday:

30 Jan 2015

CORRECTED-Connections between drug makers and educators abound

(Corrects second paragraph to say "scholarships funded by Merck, Zoetis, Cargill and others this year.")

23 Dec 2014

Powerful antibiotic for cows often misused by farmers

NEW YORK/ATLANTA - It is one of the most potent antibiotics used by U.S. cattle and dairy farmers, the key component in the top-selling drug line of Zoetis, the world’s largest animal health company.

04 Dec 2014

Competitors

  Price Chg
Novartis AG (NOVN.VX) CHF96.80 -1.30
Merck & Co., Inc. (MRK.N) $58.95 -0.43
Bayer AG (BAYGn.DE) €134.15 -2.95
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €90.36 -0.97
Eli Lilly and Co (LLY.N) $74.04 -0.26

Earnings vs. Estimates

Search Stocks